Who has invested in SURGE Therapeutics?

Camford Capital, Khosla Ventures, Intuitive Ventures, Cancer Research Institute, 8VC, Alumni Ventures are named among the investors backing SURGE Therapeutics.

SURGE Therapeutics Funding: $58M Raised, Series B (2023)

SURGE Therapeutics funding overview

SURGE Therapeutics is a Biotech company based in Cambridge, MA. SURGE Therapeutics has raised $58M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2023. The round record for SURGE Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Camford Capital, Khosla Ventures, Intuitive Ventures, Cancer Research Institute, 8VC, Alumni Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.

SURGE Therapeutics at a glance

Total raised: $58M
Latest round: Series B
Latest round date: July 2023
Industry: Biotech
Headquarters: Cambridge, MA
Notable investors: Camford Capital, Khosla Ventures, Intuitive Ventures, Cancer Research Institute, 8VC, Alumni Ventures, Pitango HealthTech, Bioluminescence Ventures

Frequently asked about SURGE Therapeutics funding

How much has SURGE Therapeutics raised?: SURGE Therapeutics has raised $58M in total disclosed funding across the rounds on record.
Who has invested in SURGE Therapeutics?: Camford Capital, Khosla Ventures, Intuitive Ventures, Cancer Research Institute, 8VC, Alumni Ventures are named among the investors backing SURGE Therapeutics.
What was the latest SURGE Therapeutics funding round?: The most recent disclosed round is a Series B, announced in July 2023.
Where is SURGE Therapeutics based?: SURGE Therapeutics is based in Cambridge, MA.
What sector does SURGE Therapeutics operate in?: SURGE Therapeutics is tracked under Biotech from Cambridge, MA, with $58M in disclosed funding.
When did SURGE Therapeutics last raise?: The last disclosed SURGE Therapeutics round closed in July 2023 at Series B.

Round data for SURGE Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.

SURGE Therapeutics Funding: $58M Raised, Series B (2023)

SURGE Therapeutics funding overview

SURGE Therapeutics at a glance

Frequently asked about SURGE Therapeutics funding

SURGE Therapeutics founders (1)

Companies related to SURGE Therapeutics (37)

Browse related funding lists (8)